Status:
TERMINATED
Yoga in Relieving Fatigue in Patients Undergoing Chemotherapy for Ovarian Cancer
Lead Sponsor:
Wake Forest University Health Sciences
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Depression
Fatigue
Eligibility:
FEMALE
18-120 years
Phase:
NA
Brief Summary
RATIONALE: Yoga may decrease fatigue, distress, and depression, and improve sleep quality in patients undergoing chemotherapy for ovarian cancer. It is not yet known whether practicing yoga in group c...
Detailed Description
OBJECTIVES: Primary * Examine the effectiveness of a restorative yoga (RY) intervention vs home yoga practice in patients undergoing chemotherapy for ovarian cancer. Secondary * Examine the effect...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Diagnosis of ovarian cancer
- Any stage disease
- Must be between 2-24 months post-primary treatment (surgery) following initial diagnosis and/or have a recurrence of ovarian cancer within the past 24 months (irrespective of current treatment status)
- Began a new chemotherapy treatment regimen within the past 4 weeks or planning to begin new chemotherapy treatment regimen within the next 4 weeks
- PATIENT CHARACTERISTICS:
- ECOG performance status 0-2
- Physically able to attend the intervention classes
- Able to understand written and spoken English
- Agree to keep psychiatric medications and doses stable during study intervention
- No medical contraindications reported by the attending physician
- No bipolar disorder, schizophrenia, psychotic depression, or any other psychotic disorder
- No usage of illicit drugs
- PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
- More than 3 months since prior yoga practice
Exclusion
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT00856453
Start Date
May 1 2009
End Date
October 1 2009
Last Update
August 9 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest University Comprehensive Cancer Center
Winston-Salem, North Carolina, United States, 27157-1096